LTTS & NVIDIA join forces to introduce Gen AI & software-defined architecture to revolutionize medical imaging. Features include image processing pipeline for noise reduction, edge & contrast enhancement, texture & color improvement, plus speckle correction. This provides enhanced visualisation & AI-based decision-making support, particularly in polyp detection & classification. Shanker Trivedi of NVIDIA states the collaboration offers value to medical tech industry by accelerating development of AI-enabled, software-defined medical devices. LTTS shares rose 1.10% to ₹4,502.90 at 11.40am on BSE.
This is a companion discussion topic for the original entry at https://www.thehindubusinessline.com/markets/stock-markets/lt-technology-partners-with-nvidia-to-introduce-gen-ai-shares-up/article67553305.ece